Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake
| Autor: | Randall R. Sakai, Dian Ming Zhang, Patrick Tso, William Sun, Liyun Ma, Chunmin C. Lo, Stephen C. Woods, W. Sean Davidson, Kevin J. Pearson, Helen E. Raybould, Min Liu |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Male
Food intake medicine.medical_specialty Time Factors Physiology animal diseases Neuropeptide Antioxidants Sincalide Rats Sprague-Dawley Hormone Antagonists Physiology (medical) Internal medicine Appetite Depressants Intestine Small medicine Animals Apolipoproteins A Cholecystokinin Meal Dose-Response Relationship Drug Chemistry Extramural digestive oral and skin physiology Apolipoprotein AIV virus diseases Feeding Behavior Rats Sprague dawley Proglumide Endocrinology hormones hormone substitutes and hormone antagonists |
| Zdroj: | American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 293:R1490-R1494 |
| ISSN: | 1522-1490 0363-6119 |
| Popis: | Apolipoprotein AIV (apo AIV) and cholecystokinin (CCK) are peptides that act both peripherally and centrally to reduce food intake by decreasing meal size. The present study examined the effects of intraperitoneally administered bolus doses of recombinant apo AIV, CCK-8, and a combination of subthreshold doses of apo AIV and CCK on 4-h food intake in rats that were fasted overnight. Apo AIV at 100 μg/kg reduced food intake significantly relative to the saline control for 1 h, as did doses of CCK-8 at or above 0.125 μg/kg. Doses of apo AIV (50 μg/kg) or CCK (0.06 μg/kg) alone had no effect on food intake. However, when these subthreshold doses of apo AIV and CCK were administered together, the combination produced a significant inhibition of food intake relative to saline controls ( P < 0.001), and the duration of the effect was longer than that caused by the administration of either apo AIV or CCK alone. The satiation effect produced by CCK-8 + apo AIV was attenuated by lorglumide, a CCK1 receptor antagonist. We conclude that, whereas the intraperitoneal administration of doses of either recombinant apo AIV or CCK at or above threshold levels reduces food intake, the coadministration of subthreshold doses of the two peptides is highly satiating and works via CCK1 receptor. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|